UA85494C2 - Pharmaceutical composition for treatment of bone tissue diseases - Google Patents

Pharmaceutical composition for treatment of bone tissue diseases

Info

Publication number
UA85494C2
UA85494C2 UAA200802015A UAA200802015A UA85494C2 UA 85494 C2 UA85494 C2 UA 85494C2 UA A200802015 A UAA200802015 A UA A200802015A UA A200802015 A UAA200802015 A UA A200802015A UA 85494 C2 UA85494 C2 UA 85494C2
Authority
UA
Ukraine
Prior art keywords
treatment
bone tissue
pharmaceutical composition
tissue diseases
vitamin
Prior art date
Application number
UAA200802015A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Сергей Васильевич Комиссаренко
Денис Владимирович Колыбо
Лариса Ивановна Апуховская
Антонина Ивановна Безусяк
Валентина Николаевна Василевская
Original Assignee
Институт Биохимии Им. А.В. Палладина Национальной Академии Наук Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Биохимии Им. А.В. Палладина Национальной Академии Наук Украины filed Critical Институт Биохимии Им. А.В. Палладина Национальной Академии Наук Украины
Priority to UAA200802015A priority Critical patent/UA85494C2/en
Publication of UA85494C2 publication Critical patent/UA85494C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to medicine, namely, to drugs containing inorganic and organic active ingredients, in particular, calcium, phosphorous compounds and vitamin D, and can be used in pharmacology and medical practice in treatment of osteoporosis and diseases connected with rarefraction of bone tissue. A composition contains as bisphosphonate dyhidrate of disodium salt of methylenebisphosphomium acid in physiologically acceptable dose, is additionally contains calcium and vitamin D.
UAA200802015A 2008-02-18 2008-02-18 Pharmaceutical composition for treatment of bone tissue diseases UA85494C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA200802015A UA85494C2 (en) 2008-02-18 2008-02-18 Pharmaceutical composition for treatment of bone tissue diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA200802015A UA85494C2 (en) 2008-02-18 2008-02-18 Pharmaceutical composition for treatment of bone tissue diseases

Publications (1)

Publication Number Publication Date
UA85494C2 true UA85494C2 (en) 2009-01-26

Family

ID=50556632

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200802015A UA85494C2 (en) 2008-02-18 2008-02-18 Pharmaceutical composition for treatment of bone tissue diseases

Country Status (1)

Country Link
UA (1) UA85494C2 (en)

Similar Documents

Publication Publication Date Title
BRPI0707235B1 (en) formulation of sublingual fentanyl without propellant, and unit dose device for sublingual administration of a sublingual fentanyl formulation
EA201690069A1 (en) THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE
NZ605887A (en) Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
EA201101518A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY
MX2014000130A (en) Methods and compositions for inhibition of bone resorption.
EA200970224A1 (en) TREATMENT OF BRAIN DISEASES
CL2010001260A1 (en) Pharmaceutical composition comprising a salt of strontium and vitamin D and a cyclodextrin, where the mass ratio between the amount of vitamin D and the amount of cyclodextrin is between 1/40 and 1/800, useful for treating or preventing osteoporosis.
MX2009006447A (en) Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate.
NZ700824A (en) Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
MX2012000275A (en) Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement.
UA105644C2 (en) Methods of treating pulmonary disorders with liposomal amikacin formulations
NZ613291A (en) Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
NZ605469A (en) Nalbuphine-based formulations and uses thereof
NZ617397A (en) Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units
NZ700924A (en) Dosage regimen for a pi-3 kinase inhibitor
BR112012027092A2 (en) methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
MX341660B (en) Ghrelin receptor agonist for treatment of dyscrasia.
AU2012377476A8 (en) Preparation and method for the prophylaxis and treatment of atypical osteoporosis
WO2010033981A3 (en) 5-azaindole bisphosphonates
UA85494C2 (en) Pharmaceutical composition for treatment of bone tissue diseases
ES2690219T3 (en) Method to fill bone cavity formations with calcium
DE602004017743D1 (en) SPHERICAL PHARMACEUTICAL COMPOSITIONS WITH VITAMIN D, CALCIUM AND PHOSPATES AND THEIR THERAPEUTIC USE
UA33494U (en) Pharmaceutical composition for treatment of bone tissue diseases
MX2010006310A (en) O-desmethyl-venlafaxine for treating major depressive disorder.
CN104490923B (en) healing ointment